dc.contributor
Institut Català de la Salut
dc.contributor
[Thompson AJ] Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, NIHR University College London Hospitals Biomedical Research Centre, Faculty of Brain Sciences, University College London, London, UK. [Moccia M] Department of Molecular Biology and Molecular Biotechnology, Federico II University of Naples, Naples, Italy Multiple Sclerosis Unit, Policlinico Federico II University Hospital, Naples, Italy. [Amato MP] Department NEUROFARBA, Section of Neurosciences, University of Florence, Florence, Italy IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy. [Calabresi PA] Department of Neurology and The Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD, USA. [Finlayson M] School of Rehabilitation Therapy, Queens University, Kingston, ON, Canada. [Hawton A] University of Exeter Medical School, University of Exeter, Exeter, UK. [Montalban X] Servei de Neurologia-Neuroimmunologia, Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain
dc.contributor
Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author
Thompson, Alan
dc.contributor.author
Moccia, Marcello
dc.contributor.author
Calabresi, Peter
dc.contributor.author
Finlayson, Marcia
dc.contributor.author
Hawton, Annemarie
dc.contributor.author
amato, Maria Pia
dc.contributor.author
Montalban, Xavier
dc.date.issued
2023-10-18T07:35:20Z
dc.date.issued
2023-10-18T07:35:20Z
dc.identifier
Thompson AJ, Moccia M, Amato MP, Calabresi PA, Finlayson M, Hawton A, et al. Do the current MS clinical course descriptors need to change and if so how? A survey of the MS community. Mult Scler J. 2023 Oct;29(11–12):1363–72.
dc.identifier
https://hdl.handle.net/11351/10463
dc.identifier
10.1177/13524585231196786
dc.identifier
001065214800001
dc.description.abstract
Multiple sclerosis; Clinical course; Progression
dc.description.abstract
Esclerosis múltiple; Curso clínico; Progresión
dc.description.abstract
Esclerosi múltiple; Curs clínic; Progressió
dc.description.abstract
Background and Objectives:
The current clinical course descriptors of multiple sclerosis (MS) include a combination of clinical and magnetic resonance imaging (MRI) features. Recently there has been a growing call to base these descriptors more firmly on biological mechanisms. We investigated the implications of proposing a new mechanism-driven framework for describing MS.
Methods:
In a web-based survey, multiple stakeholders rated the need to change current MS clinical course descriptors, the definitions of disease course and their value in clinical practice and related topics.
Results:
We received 502 responses across 49 countries. In all, 77% of the survey respondents supported changing the current MS clinical course descriptors. They preferred a framework that informs treatment decisions, aids the design and conduct of clinical trials, allows patients to understand their disease, and links disease mechanisms and clinical expression of disease. Clinical validation before dissemination and ease of communication to patients were rated as the most important aspects to consider when developing any new framework for describing MS.
Conclusion:
A majority of MS stakeholders agreed that the current MS clinical course descriptors need to change. Any change process will need to engage a wide range of affected stakeholders and be guided by foundational principles.
dc.description.abstract
This work and the International Advisory Committee on Clinical Trials in MS are funded by the European Committee for Treatment and Research in Multiple Sclerosis and the National Multiple Sclerosis Society.
dc.format
application/pdf
dc.publisher
SAGE Publications
dc.relation
Multiple Sclerosis Journal;29(11-12)
dc.relation
https://doi.org/10.1177/13524585231196786
dc.rights
Attribution 4.0 International
dc.rights
http://creativecommons.org/licenses/by/4.0/
dc.rights
info:eu-repo/semantics/openAccess
dc.subject
Esclerosi múltiple
dc.subject
Imatgeria per ressonància magnètica
dc.subject
DISEASES::Nervous System Diseases::Autoimmune Diseases of the Nervous System::Demyelinating Autoimmune Diseases, CNS::Multiple Sclerosis
dc.subject
ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Investigative Techniques::Epidemiologic Methods::Data Collection::Surveys and Questionnaires
dc.subject
ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Diagnostic Techniques and Procedures::Diagnostic Imaging::Tomography::Magnetic Resonance Imaging
dc.subject
ENFERMEDADES::enfermedades del sistema nervioso::enfermedades autoinmunitarias del sistema nervioso::enfermedades autoinmunes desmielinizantes del SNC::esclerosis múltiple
dc.subject
TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::técnicas de investigación::métodos epidemiológicos::recopilación de datos::encuestas y cuestionarios
dc.subject
TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::técnicas y procedimientos diagnósticos::diagnóstico por imagen::tomografía::imagen por resonancia magnética
dc.title
Do the current MS clinical course descriptors need to change and if so how? A survey of the MS community
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion
